
Sign up to save your podcasts
Or
Now that menopause is mainstream news, interest in hormone therapy is exploding. And so is the confusion and controversy surrounding it, as menopausal hormone therapy (aka hormone replacement therapy), which is undeniably a game changer for millions, has also become a massive business. Some practitioners are reportedly prescribing “megadoses” of estrogen–in some cases twice or even 3 or 4 times the maximum licensed dose, causing myriad medical societies to sound the alarm. Meanwhile, researchers are working overtime to catch up to provide clarity on what hormone therapy does, what it doesn’t do, who it benefits most, and for how long. This week we dig into it all with our favorite hormone doc, Dr. Carla DiGirolamo.
Carla DiGirolamo, MD, PhD, is a Double Board Certified Reproductive Endocrinologist and Obstetrician/Gynecologist specializing in infertility and menopausal medicine. She is also a Crossfit Level 1 trainer, Certified Nutrition Coach, and member of CrossFit Health. She is a MedFit Care provider and provides weekly workouts and medical updates at her Substack Athletic Aging. She has most recently become an Endocrine Consultant for Wild Health.
Resources:
The Daily Mail article on high doses of HRT here
The Joint BMS, FSRH, RCGP, RCOG, SFE and RCN Safety Alert here
Support our Partners:
Phosis: Use the code FEISTY15 for 15% off at https://www.phosis.com/
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Hettas: Use code FEISTY20 for 20% off at https://hettas.com/
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
Sign up for our FREE Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
4.9
680680 ratings
Now that menopause is mainstream news, interest in hormone therapy is exploding. And so is the confusion and controversy surrounding it, as menopausal hormone therapy (aka hormone replacement therapy), which is undeniably a game changer for millions, has also become a massive business. Some practitioners are reportedly prescribing “megadoses” of estrogen–in some cases twice or even 3 or 4 times the maximum licensed dose, causing myriad medical societies to sound the alarm. Meanwhile, researchers are working overtime to catch up to provide clarity on what hormone therapy does, what it doesn’t do, who it benefits most, and for how long. This week we dig into it all with our favorite hormone doc, Dr. Carla DiGirolamo.
Carla DiGirolamo, MD, PhD, is a Double Board Certified Reproductive Endocrinologist and Obstetrician/Gynecologist specializing in infertility and menopausal medicine. She is also a Crossfit Level 1 trainer, Certified Nutrition Coach, and member of CrossFit Health. She is a MedFit Care provider and provides weekly workouts and medical updates at her Substack Athletic Aging. She has most recently become an Endocrine Consultant for Wild Health.
Resources:
The Daily Mail article on high doses of HRT here
The Joint BMS, FSRH, RCGP, RCOG, SFE and RCN Safety Alert here
Support our Partners:
Phosis: Use the code FEISTY15 for 15% off at https://www.phosis.com/
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Hettas: Use code FEISTY20 for 20% off at https://hettas.com/
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
Sign up for our FREE Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
1,328 Listeners
1,091 Listeners
124 Listeners
193 Listeners
69 Listeners
500 Listeners
2,598 Listeners
8,004 Listeners
209 Listeners
1,215 Listeners
595 Listeners
960 Listeners
80 Listeners
19 Listeners
27 Listeners
370 Listeners
1,158 Listeners
5 Listeners
47 Listeners
205 Listeners
4 Listeners
89 Listeners